Vera Therapeutics prices public offering of 6.14M shares at $42.50, raising ~$260.9M

Vera Therapeutics, Inc.

Entered underwriting agreement Dec 9 to sell 6,138,108 shares of common stock at $42.50/share.
Gross proceeds to company approximately $260.9 million before underwriting discounts and expenses.
Underwriters fully exercised 30-day over-allotment option for 920,716 additional shares on Dec 10.
Offering expected to close Dec 11, 2025, subject to customary conditions.
Shares offered under existing automatic shelf registration statement (File No. 333-282861).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.